{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:52:45Z","timestamp":1791924765536,"version":"4.3.4"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Pediatric Neurology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.spen.2024.101155","type":"journal-article","created":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T16:19:00Z","timestamp":1726330740000},"page":"101155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Tuberous sclerosis complex: Diagnostic features, surveillance, and therapeutic strategies"],"prefix":"10.1016","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6562-8331","authenticated-orcid":false,"given":"Kristen H.","family":"Arredondo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"J\u00fclich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Steve","family":"Roach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.spen.2024.101155_bib0001","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1749-6632.1991.tb37754.x","article-title":"Epidemiology of tuberous sclerosis","volume":"615","author":"Osborne","year":"1991","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.spen.2024.101155_bib0002","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/S0140-6736(05)78872-3","article-title":"Prevalence of tuberous sclerosis estimated by capture-recapture analysis","volume":"351","author":"O'Callaghan","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.spen.2024.101155_bib0003","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pediatrneurol.2013.08.001","article-title":"Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 international tuberous sclerosis complex consensus conference","volume":"49","author":"Northrup","year":"2013","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.spen.2024.101155_bib0004","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.pediatrneurol.2021.07.011","article-title":"Updated international tuberous sclerosis complex diagnostic criteria and surveillance and management recommendations","volume":"123","author":"Northrup","year":"2021","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.spen.2024.101155_bib0005","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.pediatrneurol.2013.08.002","article-title":"International Tuberous Sclerosis Complex Consensus Group. Tuberous sclerosis complex surveillance and management: recommendations of the 2012 international tuberous sclerosis complex consensus conference","volume":"49","author":"Krueger","year":"2013","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.spen.2024.101155_bib0006","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1046\/j.1365-4362.1998.00495.x","article-title":"Skin lesions in children with tuberous sclerosis complex: their prevalence, natural course, and diagnostic significance","volume":"37","author":"J\u00f3\u017awiak","year":"1998","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.spen.2024.101155_bib0007","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/ajmg.c.31649","article-title":"The cutaneous manifestations of tuberous sclerosis complex","volume":"178","author":"Nguyen","year":"2018","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/j.spen.2024.101155_bib0008","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(08)61279-9","article-title":"Tuberous sclerosis","volume":"372","author":"Curatolo","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.spen.2024.101155_bib0009","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jaad.2017.12.027","article-title":"Fibrous cephalic plaques in tuberous sclerosis complex","volume":"78","author":"Oyerinde","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.spen.2024.101155_bib0010","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/ajmg.a.37644","article-title":"Do patients with tuberous sclerosis complex have an increased risk for malignancies?","volume":"170","author":"Peron","year":"2016","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.spen.2024.101155_bib0011","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1080\/09546634.2021.1905768","article-title":"Topical rapamycin in the treatment of facial angiofibromas in tuberous sclerosis: a systematic review based on evidence","volume":"33","author":"Cortell Fuster","year":"2022","journal-title":"J Dermatol Treat"},{"key":"10.1016\/j.spen.2024.101155_bib0012","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1177\/10600280231182421","article-title":"A review of topical sirolimus for the treatment of facial angiofibromas in tuberous sclerosis complex","volume":"58","author":"Dao","year":"2024","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.spen.2024.101155_bib0013","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1528-1167.2009.02474.x","article-title":"The natural history of epilepsy in tuberous sclerosis complex","volume":"51","author":"Chu-Shore","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.spen.2024.101155_bib0014","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13023-016-0553-5","article-title":"TuberOus SClerosis registry to increase disease Awareness (TOSCA) \u2013 baseline data on 2093 patients","volume":"12","author":"Kingswood","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.spen.2024.101155_bib0015","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1093\/jnen\/nlaa090","article-title":"Myelin pathology beyond white matter in tuberous sclerosis complex (TSC) cortical tubers","volume":"79","author":"M\u00fchlebner","year":"2020","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.spen.2024.101155_bib0016","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3389\/fneur.2020.00639","article-title":"Autism and epilepsy in patients with tuberous sclerosis complex","volume":"11","author":"Specchio","year":"2020","journal-title":"Front Neurol"},{"key":"10.1016\/j.spen.2024.101155_bib0017","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1468-1331.2009.02567.x","article-title":"Prevalence of subependymal giant cell tumors in patients with tuberous sclerosis and a review of the literature","volume":"16","author":"Adriaensen","year":"2009","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.spen.2024.101155_bib0018","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3389\/fneur.2019.00705","article-title":"Clinical characteristics of subependymal giant cell astrocytoma in tuberous sclerosis complex","volume":"10","author":"Jansen","year":"2019","journal-title":"Front Neurol"},{"key":"10.1016\/j.spen.2024.101155_bib0019","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.pediatrneurol.2013.08.017","article-title":"Subependymal giant cell astrocytoma: diagnosis, screening, and treatment. Recommendations from the international tuberous sclerosis complex consensus conference 2012","volume":"49","author":"Roth","year":"2013","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.spen.2024.101155_bib0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158476","article-title":"Long-term use of everolimus in patients with tuberous sclerosis complex: Final results from the EXIST-1 study","volume":"11","author":"Franz","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.spen.2024.101155_bib0021","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/epi4.12286","article-title":"Epilepsy in tuberous sclerosis complex: Findings from the TOSCA study","volume":"4","author":"Nabbout","year":"2019","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.spen.2024.101155_bib0022","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.pediatrneurol.2019.12.016","article-title":"Epilepsy and neurodevelopmental comorbidities in tuberous sclerosis complex: A natural history study","volume":"106","author":"Gupta","year":"2020","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.spen.2024.101155_bib0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pediatrneurol.2021.06.012","article-title":"Epilepsy is heterogeneous in early-life tuberous sclerosis complex","volume":"123","author":"Ihnen","year":"2021","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.spen.2024.101155_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2021.106631","article-title":"A reliable interictal EEG grading scale for children with infantile spasms - The 2021 BASED score","volume":"173","author":"Mytinger","year":"2021","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.spen.2024.101155_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2018.09.016","article-title":"High vigabatrin dosage is associated with lower risk of infantile spasms relapse among children with tuberous sclerosis complex","volume":"148","author":"Hussain","year":"2018","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.spen.2024.101155_bib0026","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1474-4422(16)30294-0","article-title":"Safety and effectiveness of hormonal treatment versus hormonal treatment with vigabatrin for infantile spasms (ICISS): a randomised, multicentre, open-label trial","volume":"16","author":"O'Callaghan","year":"2017","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.spen.2024.101155_bib0027","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1111\/epi.16379","article-title":"Scalp EEG spikes predict impending epilepsy in TSC infants: A longitudinal observational study","volume":"60","author":"Wu","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.spen.2024.101155_bib0028","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ana.25956","article-title":"Prevention of epilepsy in infants with tuberous sclerosis complex in the EPISTOP trial","volume":"89","author":"Kotulska","year":"2021","journal-title":"Ann Neurol"},{"key":"10.1016\/j.spen.2024.101155_bib0029","article-title":"Early treatment with vigabatrin does not decrease focal seizures or improve cognition in tuberous sclerosis complex: The PREVeNT trial","author":"Bebin","year":"2023","journal-title":"Ann Neurol"},{"key":"10.1016\/j.spen.2024.101155_bib0030","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S2352-4642(18)30099-3","article-title":"Adjunctive everolimus for children and adolescents with treatment-refractory seizures associated with tuberous sclerosis complex: post-hoc analysis of the phase 3 EXIST-3 trial","volume":"2","author":"Curatolo","year":"2018","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.spen.2024.101155_bib0031","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00381-021-05342-1","article-title":"Global and intertuberal epileptic networks in tuberous sclerosis based on stereoelectroencephalographic (sEEG) findings: a quantitative EEG analysis in pediatric subjects and surgical implications","volume":"38","author":"Alexander","year":"2022","journal-title":"Childs Nerv Syst ChNS Off J Int Soc Pediatr Neurosurg"},{"key":"10.1016\/j.spen.2024.101155_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2020.106348","article-title":"Long-term outcomes of ketogenic diet in patients with tuberous sclerosis complex-derived epilepsy","volume":"164","author":"Youn","year":"2020","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.spen.2024.101155_bib0033","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1001\/archneur.60.9.1286","article-title":"Seizure remission and antiepileptic drug discontinuation in children with tuberous sclerosis complex","volume":"60","author":"Sparagana","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.spen.2024.101155_bib0034","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1227\/neu.0000000000002214","article-title":"Epilepsy Surgery in Young Children With Tuberous Sclerosis Complex: A Novel Hybrid Multimodal Surgical Approach","volume":"92","author":"Ravindra","year":"2023","journal-title":"Neurosurgery"},{"key":"10.1016\/j.spen.2024.101155_bib0035","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.yebeh.2017.02.007","article-title":"Influence of seizures on early development in tuberous sclerosis complex","volume":"70","author":"Capal","year":"2017","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.spen.2024.101155_bib0036","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1177\/0883073810361789","article-title":"Autism spectrum disorders in tuberous sclerosis: pathogenetic pathways and implications for treatment","volume":"25","author":"Curatolo","year":"2010","journal-title":"J Child Neurol"},{"key":"10.1016\/j.spen.2024.101155_bib0037","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1177\/0883073809341272","article-title":"Attention-deficit hyperactivity disorder (ADHD) and tuberous sclerosis complex","volume":"24","author":"D'Agati","year":"2009","journal-title":"J Child Neurol"},{"key":"10.1016\/j.spen.2024.101155_bib0038","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1007\/s00467-018-4003-6","article-title":"Renal progression factors in young patients with tuberous sclerosis complex: a retrospective cohort study","volume":"33","author":"Janssens","year":"2018","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.spen.2024.101155_bib0039","doi-asserted-by":"crossref","first-page":"328","DOI":"10.5414\/CN110476","article-title":"Diagnosis and genotype-phenotype correlation in patients with PKD1\/TSC2 contiguous gene deletion syndrome","volume":"97","author":"Shang","year":"2022","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.spen.2024.101155_bib0040","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0022-5347(01)63072-6","article-title":"Renal lesion growth in children with tuberous sclerosis complex","volume":"160","author":"Ewalt","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.spen.2024.101155_bib0041","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.acra.2020.12.019","article-title":"Tuberous sclerosis complex (TSC): Renal and extrarenal imaging","volume":"29","author":"Gupta","year":"2022","journal-title":"Acad Radiol"},{"key":"10.1016\/j.spen.2024.101155_bib0042","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1093\/ndt\/gfy063","article-title":"Renal angiomyolipoma in patients with tuberous sclerosis complex: findings from the tuberous sclerosis registry to increase disease awareness","volume":"34","author":"Kingswood","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.spen.2024.101155_bib0043","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(12)61767-X","article-title":"Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial","volume":"381","author":"Bissler","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.spen.2024.101155_bib0044","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0180939","article-title":"Everolimus long-term use in patients with tuberous sclerosis complex: Four-year update of the EXIST-2 study","volume":"12","author":"Bissler","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.spen.2024.101155_bib0045","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/ajmg.1320370402","article-title":"Incidence of tuberous sclerosis in patients with cardiac rhabdomyoma","volume":"37","author":"Harding","year":"1990","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.spen.2024.101155_bib0046","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/uog.19108","article-title":"Fetal cardiac tumor: echocardiography, clinical outcome and genetic analysis in 53 cases","volume":"54","author":"Chen","year":"2019","journal-title":"Ultrasound Obstet Gynecol Off J Int Soc Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.spen.2024.101155_bib0047","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0002-9149(99)80117-9","article-title":"Tuberous sclerosis and cardiac rhabdomyoma","volume":"76","author":"Nir","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.spen.2024.101155_bib0048","doi-asserted-by":"crossref","first-page":"4907","DOI":"10.3390\/ijerph18094907","article-title":"Treatment of cardiac rhabdomyomas with mTOR inhibitors in children with tuberous sclerosis complex-a systematic review","volume":"18","author":"Sugalska","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.spen.2024.101155_bib0049","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.arcped.2021.02.008","article-title":"Evaluation of cardiac arrhythmias by electrocardiographic markers in pediatric patients who have tuberous sclerosis without cardiac rhabdomyoma","volume":"28","author":"Yozgat","year":"2021","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.spen.2024.101155_bib0050","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/adc.78.2.159","article-title":"Tuberous sclerosis complex and Wolff-Parkinson-White syndrome","volume":"78","author":"O'Callaghan","year":"1998","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.spen.2024.101155_bib0051","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0387-7604(86)80096-1","article-title":"High incidence of fundus hamartomas and clinical significance of a fundus score in tuberous sclerosis","volume":"8","author":"Kiribuchi","year":"1986","journal-title":"Brain Dev"},{"key":"10.1016\/j.spen.2024.101155_bib0052","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.5858\/2009-0576-RS.1","article-title":"Pulmonary lymphangioleiomyomatosis","volume":"134","author":"Zhang","year":"2010","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.spen.2024.101155_bib0053","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.2214\/ajr.184.3_supplement.01840s37","article-title":"Multifocal micronodular pneumocyte hyperplasia in tuberous sclerosis","volume":"184","author":"Ristagno","year":"2005","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.spen.2024.101155_bib0054","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1002\/ajmg.a.62850","article-title":"Tuberous sclerosis complex-associated nonfunctional pancreatic neuroendocrine tumors: Management and surgical outcomes","volume":"188","author":"Evans","year":"2022","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.spen.2024.101155_bib0055","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.pediatrneurol.2016.07.003","article-title":"Applying the Lessons of Tuberous Sclerosis: The 2015 Hower Award Lecture","volume":"63","author":"Roach","year":"2016","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.spen.2024.101155_bib0056","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.pediatrneurol.2013.12.002","article-title":"Mechanism-based treatment in tuberous sclerosis complex","volume":"50","author":"J\u00fclich","year":"2014","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.spen.2024.101155_bib0057","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3390\/genes15030332","article-title":"The genetics of tuberous sclerosis complex and related mTORopathies: Current understanding and future directions","volume":"15","author":"Man","year":"2024","journal-title":"Genes"},{"key":"10.1016\/j.spen.2024.101155_bib0058","doi-asserted-by":"crossref","DOI":"10.1177\/2329048X211012817","article-title":"The phenotypic spectrum of tuberous sclerosis complex: A Canadian cohort","volume":"8","author":"Alsowat","year":"2021","journal-title":"Child Neurol Open"},{"key":"10.1016\/j.spen.2024.101155_bib0059","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1038\/s41436-020-0823-4","article-title":"TSC2 pathogenic variants are predictive of severe clinical manifestations in TSC infants: results of the EPISTOP study","volume":"22","author":"Og\u00f3rek","year":"2020","journal-title":"Genet Med"},{"key":"10.1016\/j.spen.2024.101155_bib0060","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ejmg.2018.02.005","article-title":"Deep phenotyping of patients with tuberous sclerosis complex and no mutation identified in TSC1 and TSC2","volume":"61","author":"Peron","year":"2018","journal-title":"Eur J Med Genet"},{"key":"10.1016\/j.spen.2024.101155_bib0061","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/ng1294-328","article-title":"Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease\u2013a contiguous gene syndrome","volume":"8","author":"Brook-Carter","year":"1994","journal-title":"Nat Genet"},{"key":"10.1016\/j.spen.2024.101155_bib0062","doi-asserted-by":"crossref","first-page":"15816","DOI":"10.1038\/ncomms15816","article-title":"The genomic landscape of tuberous sclerosis complex","volume":"8","author":"Martin","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.spen.2024.101155_bib0063","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.ejpn.2018.08.005","article-title":"Diagnosis of tuberous sclerosis complex in the fetus","volume":"22","author":"Dragoumi","year":"2018","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.spen.2024.101155_bib0064","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.3390\/biomedicines11123241","article-title":"The evolving landscape of therapeutics for epilepsy in tuberous sclerosis complex","volume":"11","author":"Vitale","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.spen.2024.101155_bib0065","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S1474-4422(22)00213-7","article-title":"Advances in the genetics and neuropathology of tuberous sclerosis complex: edging closer to targeted therapy","volume":"21","author":"Curatolo","year":"2022","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.spen.2024.101155_bib0066","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1212\/WNL.0000000000007749","article-title":"A randomized controlled trial with everolimus for IQ and autism in tuberous sclerosis complex","volume":"93","author":"Overwater","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2024.101155_bib0067","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.581102","article-title":"Maintenance therapy with everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis - Final results from the EMINENTS study","volume":"12","author":"Bobeff","year":"2021","journal-title":"Front Neurol"},{"key":"10.1016\/j.spen.2024.101155_bib0068","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/088307389901400201","article-title":"Vigabatrin in the treatment of infantile spasms in tuberous sclerosis: literature review","volume":"14","author":"Hancock","year":"1999","journal-title":"J Child Neurol"},{"key":"10.1016\/j.spen.2024.101155_bib0069","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ejpn.2007.03.010","article-title":"Current role of vigabatrin in infantile spasms","volume":"11","author":"Parisi","year":"2007","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.spen.2024.101155_bib0070","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/dmcn.12573","article-title":"Does vigabatrin treatment for infantile spasms cause visual field defects? An international multicentre study","volume":"57","author":"Riikonen","year":"2015","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.spen.2024.101155_bib0071","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.yebeh.2016.01.012","article-title":"A lack of clinically apparent vision loss among patients treated with vigabatrin with infantile spasms: The UCLA experience","volume":"57","author":"Schwarz","year":"2016","journal-title":"Epilepsy Behav EB"},{"key":"10.1016\/j.spen.2024.101155_bib0072","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1528-1167.2008.01728.x","article-title":"Cerebral MRI abnormalities associated with vigabatrin therapy","volume":"50","author":"Pearl","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.spen.2024.101155_bib0073","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1528-1167.2008.01896.x","article-title":"Magnetic resonance imaging abnormalities associated with vigabatrin in patients with epilepsy","volume":"50","author":"Wheless","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.spen.2024.101155_bib0074","doi-asserted-by":"crossref","first-page":"eabb1703","DOI":"10.1126\/sciadv.abb1703","article-title":"Gene therapy for tuberous sclerosis complex type 2 in a mouse model by delivery of AAV9 encoding a condensed form of tuberin","volume":"7","author":"Cheah","year":"2021","journal-title":"Sci Adv"},{"key":"10.1016\/j.spen.2024.101155_bib0075","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0025-6196(12)61196-3","article-title":"Causes of death in patients with tuberous sclerosis","volume":"66","author":"Shepherd","year":"1991","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.spen.2024.101155_bib0076","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/dmcn.13352","article-title":"Causes of mortality in individuals with tuberous sclerosis complex","volume":"59","author":"Amin","year":"2017","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.spen.2024.101155_bib0077","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2021.108032","article-title":"Mortality in tuberous sclerosis complex","volume":"121","author":"Parthasarathy","year":"2021","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.spen.2024.101155_bib0078","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.ejpn.2019.09.006","article-title":"Quality of life in patients with tuberous sclerosis complex (TSC)","volume":"23","author":"Amin","year":"2019","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.spen.2024.101155_bib0079","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s42466-021-00130-3","article-title":"Quality of life and its predictors in adults with tuberous sclerosis complex (TSC): a multicentre cohort study from Germany","volume":"3","author":"Z\u00f6llner","year":"2021","journal-title":"Neurol Res Pract"},{"key":"10.1016\/j.spen.2024.101155_bib0080","doi-asserted-by":"crossref","first-page":"904","DOI":"10.3389\/fneur.2020.00904","article-title":"Burden of illness and quality of life in tuberous sclerosis complex: Findings from the TOSCA study","volume":"11","author":"Jansen","year":"2020","journal-title":"Front Neurol"},{"key":"10.1016\/j.spen.2024.101155_bib0081","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1080\/13696998.2018.1487447","article-title":"Economic burden, work, and school productivity in individuals with tuberous sclerosis and their families","volume":"21","author":"Skalicky","year":"2018","journal-title":"J Med Econ"},{"key":"10.1016\/j.spen.2024.101155_bib0082","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.3389\/fneur.2019.01116","article-title":"Tuberous sclerosis complex (TSC): Expert recommendations for provision of coordinated care","volume":"10","author":"Annear","year":"2019","journal-title":"Front Neurol"},{"key":"10.1016\/j.spen.2024.101155_bib0083","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1055\/s-2008-1041360","article-title":"Diagnosis and management of neurocutaneous syndromes","volume":"8","author":"Roach","year":"1988","journal-title":"Semin Neurol"},{"key":"10.1016\/j.spen.2024.101155_bib0084","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1177\/08830738040190090301","article-title":"Diagnosis of tuberous sclerosis complex","volume":"19","author":"Roach","year":"2004","journal-title":"J Child Neurol"},{"key":"10.1016\/j.spen.2024.101155_bib0085","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/B978-0-444-62702-5.00006-8","article-title":"Tuberous sclerosis complex","volume":"132","author":"Islam","year":"2015","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.spen.2024.101155_bib0086","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0031-3955(16)38367-5","article-title":"Neurocutaneous syndromes","volume":"39","author":"Roach","year":"1992","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.spen.2024.101155_bib0087","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S1072-7515(98)00239-7","article-title":"The tuberous sclerosis complex: a comprehensive review","volume":"187","author":"Weiner","year":"1998","journal-title":"J Am Coll Surg"}],"container-title":["Seminars in Pediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107190912400041X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107190912400041X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T04:03:01Z","timestamp":1732766581000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S107190912400041X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":87,"alternative-id":["S107190912400041X"],"URL":"https:\/\/doi.org\/10.1016\/j.spen.2024.101155","relation":{},"ISSN":["1071-9091"],"issn-type":[{"value":"1071-9091","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tuberous sclerosis complex: Diagnostic features, surveillance, and therapeutic strategies","name":"articletitle","label":"Article Title"},{"value":"Seminars in Pediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.spen.2024.101155","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101155"}}